Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

University Hospital Rotterdam, Rotterdam, Netherlands.

Survival: monthsCountry:Netherlands
Toxiciy Grade:4City/State/Province:Rotterdam
Treatments:ChemotherapyHospital:University Hospital Rotterdam
Drugs:Journal:Link
Date:Feb 2002

Description:

Patients: This Phase II trial involved 32 patients with malignant pleural mesothelioma. None of these patients had received prior chemotherapy.

Treatment: The treatment consisted of two chemotherapy drugs, gemcitabine (gemzar) and cisplatin (platinol).

Toxicity: Grade 4 toxicities included nausea and vomiting. Grade 3 toxicities included hematologic, nausea and vomiting, fatigue anorexia, diarrhea, neurotoxicity, cardiovascular.

Results: The median survival from the start of treatment was 9.4 months.

Support: This study was supported in part by Lilly BV. Lilly markets gemzar.

Correspondence: JP van Meerbeeck, MD





Back